IRIS PubliCatt
PubliCatt è il repository istituzionale ad accesso aperto dell'Università Cattolica del Sacro Cuore, dove gli utenti autorizzati afferenti all'Ateneo provvedono direttamente e autonomamente a depositare e a rendere visibili le proprie pubblicazioni, inserendo i dati descrittivi del documento stesso ("metadati", quali il titolo, autore, abstract, etc.) e, laddove possibile, il testo della pubblicazione stessa (full-text).
PubliCatt utilizza la piattaforma IRIS (Institutional Research Information System) sviluppata da CINECA.
EnglishAcute exudative polymorphous vitelliform maculopathy is a rare retinal disease characterized by bilateral serous macular detachment and subretinal accumulation of yellowish deposits resembling Best dystrophy lesions. Corticosteroid systemic therapy has been used empirically in the attempt to treat this retinal disorder with mixed results. Thus, the benefit of corticosteroid remains undetermined. To our knowledge, we report the first case of acute exudative polymorphous vitelliform maculopathy (AEPVM) treated in one eye with intravitreal dexamethasone implant (Ozurdex; Allergan, Inc., Irvine, California, USA).
Scupola, A., Abed, E., Sammarco, M. G., Traina, S., Villano, A., Grimaldi, G., Blasi, M. A., Intravitreal dexamethasone implant for acute exudative polymorphous vitelliform maculopathy, <<EUROPEAN JOURNAL OF OPHTHALMOLOGY>>, 2014; 24 (5): 803-807. [doi:10.5301/ejo.5000477] [http://hdl.handle.net/10807/63456]
| Autori: | ||
| Titolo: | Intravitreal dexamethasone implant for acute exudative polymorphous vitelliform maculopathy | |
| Digital Object Identifier (DOI): | http://dx.doi.org/10.5301/ejo.5000477 | |
| Data di pubblicazione: | 2014 | |
| Abstract: | Acute exudative polymorphous vitelliform maculopathy is a rare retinal disease characterized by bilateral serous macular detachment and subretinal accumulation of yellowish deposits resembling Best dystrophy lesions. Corticosteroid systemic therapy has been used empirically in the attempt to treat this retinal disorder with mixed results. Thus, the benefit of corticosteroid remains undetermined. To our knowledge, we report the first case of acute exudative polymorphous vitelliform maculopathy (AEPVM) treated in one eye with intravitreal dexamethasone implant (Ozurdex; Allergan, Inc., Irvine, California, USA). | |
| Lingua: | Inglese | |
| Rivista: | ||
| Citazione: | Scupola, A., Abed, E., Sammarco, M. G., Traina, S., Villano, A., Grimaldi, G., Blasi, M. A., Intravitreal dexamethasone implant for acute exudative polymorphous vitelliform maculopathy, <<EUROPEAN JOURNAL OF OPHTHALMOLOGY>>, 2014; 24 (5): 803-807. [doi:10.5301/ejo.5000477] [http://hdl.handle.net/10807/63456] | |
| Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |
File in questo prodotto:
Copyright © 2021